Welcome to our dedicated page for Option Care Health news (Ticker: OPCH), a resource for investors and traders seeking the latest updates and insights on Option Care Health stock.
Option Care Health, Inc. (symbol: OPCH) is the largest independent provider of home and alternate site infusion services in the United States. With a dedicated team of over 7,500 members, including more than 4,500 clinicians, the company is at the forefront of delivering compassionate care to patients with acute and chronic conditions across all 50 states.
Formed from the merger of Option Care and BioScrip in August 2019, the company has successfully integrated its operations to create a unified national team. This merger has enabled Option Care Health to leverage its clinical leadership, extensive expertise, and national scale to reimagine the infusion care experience for patients, customers, and employees.
Option Care Health specializes in providing a variety of infusion therapies, including treatments for bleeding disorders, neurological conditions, heart failure, anti-infectives, and chronic inflammatory disorders. The company operates through home and alternate site settings, ensuring that patients receive care in a comfortable and convenient environment.
Recent achievements include strong financial performance, as highlighted in the company's third-quarter 2023 results. The CEO, John C. Rademacher, emphasized the outstanding clinical outcomes and extraordinary patient care that have contributed to these solid financial results. For the full year 2023, the company expects to generate substantial revenues and has provided updated financial guidance, reflecting its robust financial health.
The company's commitment to innovation is evident in its continuous efforts to elevate standards of care. Its clinical leadership and national scale allow Option Care Health to implement cutting-edge solutions that improve patient outcomes, reduce costs, and enhance the overall care experience.
Option Care Health's significant partnerships and collaborations further strengthen its market position. The company recently announced an increase in its share repurchase program authorization from $250 million to $500 million, demonstrating its confidence in its financial stability and future growth prospects.
For more information and the latest updates, please visit Option Care Health's Investor Relations page.
Option Care Health announced an affiliate of Walgreens Boots Alliance will sell 11 million shares of the Company’s common stock at $33.25 per share in a secondary offering. This represents about 6% of the current shares outstanding. The offering is expected to close on August 18, 2022, subject to customary conditions. Goldman Sachs is the underwriter for the offering. Option Care Health will not receive any proceeds from this transaction. A shelf registration statement was filed with the SEC for these shares.
Option Care Health announced an underwritten secondary offering of 11 million shares by an affiliate of Walgreens Boots Alliance, representing approximately 6.0% of its outstanding shares. The offering, managed by Goldman Sachs, will not generate proceeds for the company. A shelf registration statement has been filed with the SEC to facilitate this process. Although the offering can potentially affect stock availability, it is not expected to impact the company's financial position directly.
Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., has announced its participation in two investor conferences. The BofA Securities SMID Cap Ideas Conference will be held virtually on August 10, 2022, featuring a fireside chat at 9:40 am ET. Following that, the Morgan Stanley 20th Annual Global Healthcare Conference is set for September 12, 2022, in New York, with a fireside chat at 8:45 am ET. Additional information and presentations will be available online.
Option Care Health reported strong second quarter 2022 financial results, with net revenue of $980.8 million, a 14.0% increase from $860.3 million in Q2 2021. Gross profit reached $216.9 million (22.1% of revenue), up 9.0% year-over-year. Net income was $33.9 million ($0.19 per share), compared to $31.8 million ($0.18 per share) last year. Adjusted EBITDA increased 17.0% to $85.2 million. Cash flow from operations improved to $104.4 million. The company also completed the acquisition of Specialty Pharmacy Nursing Network for $60.0 million.
Option Care Health (NASDAQ: OPCH) will announce its second-quarter results on July 27, 2022, before market opening. The management team will host a conference call at 8:30 a.m. ET to discuss the results. Option Care Health is recognized as the largest independent provider of home and alternate site infusion services in the U.S., employing over 7,000 individuals, including 4,000 clinicians. The company is dedicated to enhancing patient care for both acute and chronic conditions across all 50 states.
Option Care Health (NASDAQ: OPCH), the largest independent provider of home and alternate site infusion services in the U.S., announced its participation in several upcoming investor conferences. These include the William Blair 42nd Annual Growth Stock Conference on June 7, 2022, the Jefferies Healthcare Conference on June 9, 2022, and the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022. Each event features a fireside chat presentation. More details and webcast links can be found on their investor relations website.
Option Care Health, the largest independent national provider of home infusion services, will participate in the BofA Securities 2022 Healthcare Conference on May 10, 2022, in Las Vegas. The event will feature a fireside chat at 11:20 AM PT, with an audio replay available online afterward. Option Care Health employs over 7,000 team members, including more than 4,000 clinicians, dedicated to improving patient care for acute and chronic conditions across all 50 states. For more information, visit OptionCareHealth.com.
Option Care Health reported a robust first quarter for 2022, achieving net revenue of $915.8 million, a 20.6% increase from $759.2 million in Q1 2021. The gross profit rose to $200.9 million, representing 21.9% of net revenue. The company posted a net income of $30.3 million ($0.17 per share), recovering from a net loss of $2.9 million the prior year. Additionally, Adjusted EBITDA surged by 48.9% to $77.8 million. For 2022, guidance projects revenue between $3.75 billion and $3.90 billion.
Option Care Health (Nasdaq: OPCH) announced the acquisition of Specialty Pharmacy Nursing Network Inc. (SPNN) for $60 million in cash, finalized on April 11, 2022. This acquisition enhances Option Care's nursing capabilities, expanding its team to over 2,900 nurses nationwide. SPNN, a leader in providing specialized nursing resources, will continue its operations as a separate unit within Option Care Health. CEO John Rademacher emphasized that this move aligns with their strategy to improve infusion care and ensures future growth opportunities.
Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., announced its first quarter financial results will be released on April 28, 2022. The management team will host a conference call at 8:30 a.m. E.T. to discuss these results. Investors can access the call by phone or through a live audio webcast. A replay will be available for on-demand listening afterward. Option Care Health serves patients with acute and chronic conditions nationwide, employing over 7,000 team members, including more than 4,000 clinicians.
FAQ
What is the current stock price of Option Care Health (OPCH)?
What is the market cap of Option Care Health (OPCH)?
What services does Option Care Health provide?
How many states does Option Care Health operate in?
Who are the key team members at Option Care Health?
What recent financial achievements has Option Care Health reported?
What was the impact of the merger between Option Care and BioScrip?
How does Option Care Health ensure quality care?
What is the focus of Option Care Health's innovation?
What is Option Care Health's share repurchase program?
Where can investors find more information about Option Care Health?
How can patients receive care from Option Care Health?
